Table 2 Cox regression hazard models on death and MACE for all or aged over 65 patients

Death

Death

Variable

Hazard ratio [95%CI]

p value

Hazard ratio [95%CI]

p value

Variable

Hazard ratio [95%CI]

p value

Hazard ratio [95%CI]

p value

Model 1

Age (per 1 year)

1.17

< 0.001

1.15

< 0.001

Model 1

Age (per 1 year)

1.23

< 0.001

1.20

0.001

[1.10–1.26]

[1.09–1.24]

[1.12–1.38]

[1.08–1.35]

cLVH (+ vs. −)

7.35

< 0.001

3.32

0.029

cLVH (+ vs. −)

6.30

0.001

3.51

0.039

[2.67–20.30]

[1.13–9.70]

[2.04–19.45]

[1.06–11.58]

Model 2

Age (per 1 year)

1.17

< 0.001

1.15

< 0.001

Model 2

Age (per 1 year)

1.23

< 0.001

1.21

0.001

[1.10–1.26]

[1.08–1.23]

[1.12–1.38]

[1.08–1.36]

RAS inhibitor (− vs. +)

5.09

0.001

1.86

0.229

RAS inhibitor (− vs. +)

2.35

0.121

1.53

0.444

[1.89–13.70]

[0.68–5.13]

[0.80–6.90]

[0.52–4.53]

cLVH (+ vs. −)

7.35

< 0.001

3.22

0.031

cLVH (+ vs. −)

6.30

0.001

3.43

0.039

[2.67–20.30]

[1.11–9.30]

[2.04–19.45]

[1.06–11.04]

Model 3

Age (per 1 year)

1.17

< 0.001

1.15

< 0.001

Model 3

Age (per 1 year)

1.23

< 0.001

1.19

0.001

[1.10–1.26]

[1.08–1.23]

[1.12–1.38]

[1.07–1.36]

Log CRP (per 0.523)

1.94

0.026

1.22

0.661

log CRP (per 0.523)

2.38

0.025

1.25

0.711

[1.00–3.31]

[0.46–2.73]

[1.05–4.97]

[0.36–3.84]

cLVH (+ vs. −)

7.35

< 0.001

3.16

0.040

cLVH (+ vs. −)

6.30

0.001

3.38

0.046

[2.67–20.30]

[1.07–9.98]

[2.04–19.45]

[1.00–11.40]

Model 4

Age (per 1 year)

1.17

< 0.001

1.15

< 0.001

Model 4

Age (per 1 year)

1.23

< 0.001

1.20

0.001

[1.10–1.26]

[1.08–1.24]

[1.12–1.38]

[1.08–1.35]

CVD before PD initiation (+ vs. −)

2.22

0.141

1.21

0.732

CVD before PD initiation (+ vs. −)

1.05

0.931

1.06

0.921

[0.77–6.40]

[0.41–3.57]

[0.32–3.42]

[0.32–3.53]

cLVH (+ vs. −)

7.35

< 0.001

3.33

0.028

cLVH (+ vs. −)

6.30

0.001

3.52

0.039

[2.67–20.30]

[1.14–9.73]

[2.04–19.45]

[1.07–11.63]

Model 5

Pulse pressure

1.06

< 0.001

1.03

0.052

Model 5

Pulse pressure

1.04

0.011

1.01

0.661

[1.03–1.10]

[1.00–1.07]

[1.01–1.07]

[0.97–1.05]

RAS inhibitor (− vs. +)

5.09

0.001

2.48

0.109

RAS inhibitor (− vs. +)

2.35

0.121

1.37

0.620

[1.89–13.70]

[0.82–7.53]

[0.80–6.90]

[0.39–4.75]

cLVH (+ vs. −)

7.35

< 0.001

3.23

0.066

cLVH (+ vs. −)

6.30

0.001

4.68

0.028

[2.67–20.30]

[0.92–11.30]

[2.04–19.45]

[1.18–18.56]

MACE

MACE

Variable

Hazard ratio [95%CI]

p value

Hazard ratio [95%CI]

p value

Variable

Hazard ratio [95%CI]

p value

Hazard ratio [95%CI]

p value

Model 1

Age (per 1 year)

1.09

< 0.001

1.07

< 0.001

Model 1

Age (per 1 year)

1.10

0.008

1.07

0.059

[1.05–1.12]

[1.04–1.11]

[1.02–1.18]

[1.00–1.15]

CVD before PD initiation (+ vs. −)

3.48

< 0.001

2.14

0.038

cLVH (+ vs. −)

3.69

0.002

2.97

0.013

[1.75–6.91]

[1.04–4.38]

[1.63–8.35]

[1.26–7.01]

cLVH (+ vs. −)

3.06

< 0.001

2.13

0.032

[1.58–5.92]

[1.07–4.25]

Model 2

Age (per 1 year)

1.09

< 0.001

1.08

< 0.001

Model 2

Age (per 1 year)

1.10

0.008

1.05

0.174

[1.05–1.12]

[1.04–1.12]

[1.02–1.18]

[0.98–1.14]

CVD before PD initiation (+ vs. −)

3.48

< 0.001

2.31

0.026

CVD before PD initiation (+ vs. −)

1.77

0.192

1.35

0.527

[1.75–6.91]

[1.11–4.84]

[0.77–4.05]

[0.53–3.42]

Diabetes

1.85

0.066

2.05

0.047

log CRP (per 0.523)

2.22

0.007

1.53

0.273

(+ vs. −)

[0.96–3.55]

[1.01–4.17]

[1.20–3.90]

[0.67–3.11]

RAS inhibitor (− vs. +)

1.79

0.147

0.70

0.431

cLVH (+ vs. −)

3.69

0.002

2.81

0.025

[0.81–3.92]

[0.29–1.69]

[1.63–8.35]

[1.12–6.92]

log CRP (per 0.523)

1.33

0.221

1.03

0.932

[0.80–2.02]

[0.58–1.82]

cLVH (+ vs. −)

3.06

< 0.001

1.79

0.138

[1.58–5.92]

[0.83–3.87]